These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33831941)

  • 1. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept.
    Chavarot N; Ouedrani A; Marion O; Leruez-Ville M; Vilain E; Baaziz M; Del Bello A; Burger C; Sberro-Soussan R; Martinez F; Chatenoud L; Abravanel F; Anglicheau D; Izopet J; Couat C; Zuber J; Legendre C; Lanternier F; Kamar N; Scemla A
    Transplantation; 2021 Sep; 105(9):e94-e95. PubMed ID: 33831941
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept-treated Renal Transplant Patients.
    Dolff S; Korth J; Jahn M; Kribben A; Witzke O; Wilde B
    Transplantation; 2021 Sep; 105(9):e99. PubMed ID: 33966023
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcomes of SARS-CoV-2 infection in kidney transplant recipients on belatacept: a single-center experience.
    Feller F; Azar MM; Marvin J; Cohen E; Virmani S; Malinis M
    Transpl Infect Dis; 2024 Apr; 26(2):e14253. PubMed ID: 38351494
    [No Abstract]   [Full Text] [Related]  

  • 4. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
    Chavarot N; Morel A; Leruez-Ville M; Vilain E; Divard G; Burger C; Serris A; Sberro-Soussan R; Martinez F; Amrouche L; Bererhi L; Lanternier F; Legendre C; Zuber J; Anglicheau D; Scemla A
    Am J Transplant; 2021 Dec; 21(12):4043-4051. PubMed ID: 34431207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.
    Mitchell J; Kim J; Alejo JL; Chiang TP; Karaba AH; Blankson JN; Aytenfisu TY; Chang A; Abedon AT; Avery RK; Tobian AA; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e264-e265. PubMed ID: 35289776
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.
    Ou MT; Boyarsky BJ; Chiang TPY; Bae S; Werbel WA; Avery RK; Tobian AAR; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 Sep; 105(9):2119-2123. PubMed ID: 34028386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.
    Noble J; Langello A; Bouchut W; Lupo J; Lombardo D; Rostaing L
    Transplantation; 2021 Nov; 105(11):e259-e260. PubMed ID: 34387243
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.
    Kühne JF; Neudörfl C; Beushausen K; Keil J; Malysheva S; Wandrer F; Haller H; Messerle M; Blume C; Neuenhahn M; Schlott F; Hammerschmidt W; Zeidler R; Falk CS
    Transpl Immunol; 2020 Aug; 61():101291. PubMed ID: 32330566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
    Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
    Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Laurent C; Etienne I; Lemoine M; Lebourg L; Hanoy M; Le Roy F; Nezam D; Farce F; Plantier JC; Boyer O; Guerrot D; Candon S
    Kidney Int; 2021 Dec; 100(6):1337-1340. PubMed ID: 34619232
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France.
    Bertrand D; Brunel M; Lebourg L; Scemla A; Lemoine M; Amrouche L; Laurent C; Legendre C; Guerrot D; Anglicheau D; Sberro-Soussan R
    Transpl Int; 2023; 36():11328. PubMed ID: 37554319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
    Budde K; Prashar R; Haller H; Rial MC; Kamar N; Agarwal A; de Fijter JW; Rostaing L; Berger SP; Djamali A; Leca N; Allamassey L; Gao S; Polinsky M; Vincenti F
    J Am Soc Nephrol; 2021 Dec; 32(12):3252-3264. PubMed ID: 34706967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.
    Badell IR; Bray RA; Elbein R; Chami AS; Easley KA; Pastan SO; Guasch A; Gebel HM; Adams AB; Larsen CP
    Transplantation; 2021 Dec; 105(12):e395-e396. PubMed ID: 34818307
    [No Abstract]   [Full Text] [Related]  

  • 17. Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.
    Del Bello A; Marion O; Milongo D; Rostaing L; Kamar N
    Expert Rev Clin Pharmacol; 2016; 9(2):215-27. PubMed ID: 26691282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.
    Tometten I; Landmann S; Kantauskaite M; Lamberti J; Hillebrandt J; Müller L; Kittel M; Kolb T; Ivens K; Schmitz M; Voges A; Adams O; Andrée M; Schaal H; Lübke N; Königshausen E; Rump LC; Stegbauer J; Timm J
    J Infect Dis; 2023 Mar; 227(5):641-650. PubMed ID: 36408631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
    Stumpf J; Tonnus W; Paliege A; Rettig R; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Tonn T; Hugo C
    Transplantation; 2021 Nov; 105(11):e267-e269. PubMed ID: 34342963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine.
    Abravanel F; Marion O; Del Bello A; Beunon T; Romieu-Mourez R; Couat C; Pucelle M; Staes L; Guitard J; Esposito L; Faguer S; Kamar N; Izopet J
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.